Broad-spectrum -lactams for treating experimental peritonitis in mice due to Escherichia coli producing plasmid-encoded cephalosporinases | Zendy

Sophie Vimont | Zendy; Dominique Aubert | Zendy; JeanXavier Mazoit | Zendy; Laurent Poirel | Zendy; Patrice Nordmann | Zendy

Open Access

Broad-spectrum -lactams for treating experimental peritonitis in mice due to Escherichia coli producing plasmid-encoded cephalosporinases

Author(s) -

Sophie Vimont,

Dominique Aubert,

JeanXavier Mazoit,

Laurent Poirel,

Patrice Nordmann

Publication year - 2007

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkm317

Subject(s) - cefepime , piperacillin , ceftazidime , imipenem , microbiology and biotechnology , tazobactam , piperacillin/tazobactam , escherichia coli , peritonitis , plasmid , medicine , biology , antibiotics , antibiotic resistance , bacteria , pseudomonas aeruginosa , surgery , dna , biochemistry , genetics , gene

To investigate the correlation between in vitro activity and in vivo efficacy of broad-spectrum beta-lactams for treating experimental infections due to Escherichia coli expressing two types of plasmid-mediated AmpC-type beta-lactamases, LAT-1 and FOX-1.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research